The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Irritable Bowel Syndrome Treatment Market Research Report 2024

Global Irritable Bowel Syndrome Treatment Market Research Report 2024

Publishing Date : Jan, 2024

License Type :
 

Report Code : 1804958

No of Pages : 77

Ask Your Query

Synopsis

Irritable bowel syndrome is a functional gastrointestinal disorder of gut that may be characterized by colon muscle contractions. Irritable bowel syndrome is a common disorder. There is no complete cure for the irritable bowel syndrome. Medicines used in irritable bowel syndrome are effective in decreasing the symptoms.

The global Irritable Bowel Syndrome Treatment market was valued at US$ 4737.2 million in 2023 and is anticipated to reach US$ 6127.9 million by 2030, witnessing a CAGR of 3.8% during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Irritable Bowel Syndrome Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Irritable Bowel Syndrome Treatment.

Report Scope

The Irritable Bowel Syndrome Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Irritable Bowel Syndrome Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Irritable Bowel Syndrome Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company (Partial List)

  • Bausch Health
  • Sucampo Pharmaceuticals
  • Abbott Laboratories
  • Lexicon Pharmaceuticals
  • Salix Pharmaceuticals
  • Ironwood Pharmaceuticals
  • GlaxoSmithKline
  • Allergan

Segment by Type

  • Irritable Bowel Syndrome with Constipation
  • Irritable Bowel Syndrome with Diarrhea
  • Irritable Bowel Syndrome with alternating Constipationand Diarrhea

Segment by Application

  • Hospitals
  • Clinics
  • Homecare Settings

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, India, Australia, China Taiwan, Indonesia, Thailand, Malaysia)
  • Latin America (Mexico, Brazil, Argentina)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Irritable Bowel Syndrome Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Irritable Bowel Syndrome Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Irritable Bowel Syndrome with Constipation
1.2.3 Irritable Bowel Syndrome with Diarrhea
1.2.4 Irritable Bowel Syndrome with alternating Constipationand Diarrhea
1.3 Market by Application
1.3.1 Global Irritable Bowel Syndrome Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Homecare Settings
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Irritable Bowel Syndrome Treatment Market Perspective (2019-2030)
2.2 Irritable Bowel Syndrome Treatment Growth Trends by Region
2.2.1 Global Irritable Bowel Syndrome Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Irritable Bowel Syndrome Treatment Historic Market Size by Region (2019-2024)
2.2.3 Irritable Bowel Syndrome Treatment Forecasted Market Size by Region (2025-2030)
2.3 Irritable Bowel Syndrome Treatment Market Dynamics
2.3.1 Irritable Bowel Syndrome Treatment Industry Trends
2.3.2 Irritable Bowel Syndrome Treatment Market Drivers
2.3.3 Irritable Bowel Syndrome Treatment Market Challenges
2.3.4 Irritable Bowel Syndrome Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Irritable Bowel Syndrome Treatment Players by Revenue
3.1.1 Global Top Irritable Bowel Syndrome Treatment Players by Revenue (2019-2024)
3.1.2 Global Irritable Bowel Syndrome Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Irritable Bowel Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Irritable Bowel Syndrome Treatment Revenue
3.4 Global Irritable Bowel Syndrome Treatment Market Concentration Ratio
3.4.1 Global Irritable Bowel Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Irritable Bowel Syndrome Treatment Revenue in 2023
3.5 Irritable Bowel Syndrome Treatment Key Players Head office and Area Served
3.6 Key Players Irritable Bowel Syndrome Treatment Product Solution and Service
3.7 Date of Enter into Irritable Bowel Syndrome Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Irritable Bowel Syndrome Treatment Breakdown Data by Type
4.1 Global Irritable Bowel Syndrome Treatment Historic Market Size by Type (2019-2024)
4.2 Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Type (2025-2030)
5 Irritable Bowel Syndrome Treatment Breakdown Data by Application
5.1 Global Irritable Bowel Syndrome Treatment Historic Market Size by Application (2019-2024)
5.2 Global Irritable Bowel Syndrome Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Irritable Bowel Syndrome Treatment Market Size (2019-2030)
6.2 North America Irritable Bowel Syndrome Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Irritable Bowel Syndrome Treatment Market Size by Country (2019-2024)
6.4 North America Irritable Bowel Syndrome Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Irritable Bowel Syndrome Treatment Market Size (2019-2030)
7.2 Europe Irritable Bowel Syndrome Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Irritable Bowel Syndrome Treatment Market Size by Country (2019-2024)
7.4 Europe Irritable Bowel Syndrome Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size (2019-2030)
8.2 Asia-Pacific Irritable Bowel Syndrome Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Irritable Bowel Syndrome Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Irritable Bowel Syndrome Treatment Market Size (2019-2030)
9.2 Latin America Irritable Bowel Syndrome Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Irritable Bowel Syndrome Treatment Market Size by Country (2019-2024)
9.4 Latin America Irritable Bowel Syndrome Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size (2019-2030)
10.2 Middle East & Africa Irritable Bowel Syndrome Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Irritable Bowel Syndrome Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bausch Health
11.1.1 Bausch Health Company Detail
11.1.2 Bausch Health Business Overview
11.1.3 Bausch Health Irritable Bowel Syndrome Treatment Introduction
11.1.4 Bausch Health Revenue in Irritable Bowel Syndrome Treatment Business (2019-2024)
11.1.5 Bausch Health Recent Development
11.2 Sucampo Pharmaceuticals
11.2.1 Sucampo Pharmaceuticals Company Detail
11.2.2 Sucampo Pharmaceuticals Business Overview
11.2.3 Sucampo Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
11.2.4 Sucampo Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2019-2024)
11.2.5 Sucampo Pharmaceuticals Recent Development
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Detail
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Irritable Bowel Syndrome Treatment Introduction
11.3.4 Abbott Laboratories Revenue in Irritable Bowel Syndrome Treatment Business (2019-2024)
11.3.5 Abbott Laboratories Recent Development
11.4 Lexicon Pharmaceuticals
11.4.1 Lexicon Pharmaceuticals Company Detail
11.4.2 Lexicon Pharmaceuticals Business Overview
11.4.3 Lexicon Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
11.4.4 Lexicon Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2019-2024)
11.4.5 Lexicon Pharmaceuticals Recent Development
11.5 Salix Pharmaceuticals
11.5.1 Salix Pharmaceuticals Company Detail
11.5.2 Salix Pharmaceuticals Business Overview
11.5.3 Salix Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
11.5.4 Salix Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2019-2024)
11.5.5 Salix Pharmaceuticals Recent Development
11.6 Ironwood Pharmaceuticals
11.6.1 Ironwood Pharmaceuticals Company Detail
11.6.2 Ironwood Pharmaceuticals Business Overview
11.6.3 Ironwood Pharmaceuticals Irritable Bowel Syndrome Treatment Introduction
11.6.4 Ironwood Pharmaceuticals Revenue in Irritable Bowel Syndrome Treatment Business (2019-2024)
11.6.5 Ironwood Pharmaceuticals Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Irritable Bowel Syndrome Treatment Introduction
11.7.4 GlaxoSmithKline Revenue in Irritable Bowel Syndrome Treatment Business (2019-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Allergan
11.8.1 Allergan Company Detail
11.8.2 Allergan Business Overview
11.8.3 Allergan Irritable Bowel Syndrome Treatment Introduction
11.8.4 Allergan Revenue in Irritable Bowel Syndrome Treatment Business (2019-2024)
11.8.5 Allergan Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock